NTRS — Northern Trust Corporation

Market sentiment is best characterized as neutral-to-cautious. Analyst consensus is Hold (12 buy / 18 hold / 5 sell), and the consensus target of $183.17 sits below the $186.27 price. The strong Q2 beat and 10% dividend increase are offset by the one-time Visa gain, a stock near its 52-week high, and limited expected upside to analyst price targets.

Revenue has climbed from roughly $3.21B in Q3 2023 to $3.51–$3.68B through 2025, then stepped up to $3.79B in Q1 2026 and $4.21B in Q2 2026. The Q2 jump is inflated by the $525.4M pre-tax Visa gain; organic revenue still grew 13%, helped by a second consecutive quarter of more than 700 bps of positive operating leverage. Diluted EPS trended from $1.49 in Q3 2023 to $2.13–$2.42 through 2025, with the $4.23 Q2 2026 figure clearly distorted by the one-time item. Underneath that, the trend is positive: eight straight quarters of organic trust-fee growth, double-digit NII growth, and continued expense discipline. The FMP cash-flow metrics are noisy for a custodian bank, with operating cash flow negative in the last two reported quarters, so those should be read with skepticism.

At $186.27, NTRS trades at 15.9x trailing EPS, modestly above its 5-year average of 14.7x. Price/sales is 2.24x vs a 5-year average of 2.15x, and price/book is 2.56x. The forward EPS estimate of $11.47 is below TTM EPS of $12.18, so the stock is actually about 16.2x forward earnings after stripping out the Visa gain. That is fair to slightly rich, not cheap. The 1.88% dividend yield and 0.43 PEG look attractive on the surface, but the low PEG conflicts with the lower forward EPS estimate and should not be the main valuation hook.

The stock has rallied roughly 54% off its 52-week low, and the market is paying up for quality: organic trust-fee growth, double-digit NII, clean CCAR, and a dividend raise. But TTM EPS is flattered by the Visa gain, and next-year consensus EPS of $11.47 is lower, meaning the current price already embeds an expectation that core growth continues. If Q3 delivers ex-item core EPS growth and sustained operating leverage, the premium can hold; if the one-off boost masks a slowdown, $186 is above fair value and the stock likely drifts toward the $170s.

As of 2026-08-27, RSI is 52.35, neutral rather than overbought or oversold. Price is 0.15% below its 20-day SMA, 2.04% above its 50-day SMA, and 18.82% above its 200-day SMA. That is a long-term uptrend with near-term consolidation. A clean entry would be a pullback toward the 50-day area around $182.50 or a decisive close through the 52-week high near $195.78; otherwise the tape is balanced.

• Rate environment: an easing bias and stabilizing deposit costs support NII; sharper rate cuts would compress net interest margin.
• Equity market dependence: with AUC/A of $20.0T and AUM of $2.0T, fee revenue is highly levered to market levels and FX movements.
• Regulatory capital: clean CCAR with a 2.5% stress capital buffer allows continued buybacks and the dividend raise.
• Sector competition: asset-servicing fees face pricing pressure from peers, and digital/data investments are necessary but costly.
• Institutional demand: client interest in data reporting, digital asset services, and fund servicing is a growth tailwind.

• Q3 2026 earnings in mid-to-late October — the first clean test of core EPS and organic trust-fee growth without the Visa gain.
• Barclays Global Financial Services Conference on September 14, 2026 — possible strategic and business-update catalyst.
• Ex-dividend date on September 4, 2026 for the raised $0.88 quarterly dividend.
• Continued equity market gains or institutional inflows pushing AUC/A above $20T and AUM above $2T.
• Further capital-return announcements if the balance sheet stays above regulatory minimums.

• The one-time Visa gain flatters 2026 results; normalized EPS and FCF are lower than headline numbers.
• Stock is trading above the analyst consensus target of $183.17, with limited valuation cushion.
• A sustained market correction would reduce AUM/AUC-based fees and pressure capital markets income.
• Interest rate cuts could squeeze NII if deposit costs fall more slowly than asset yields.
• Execution and regulatory risk in digital asset/data partnerships plus competitive pressure in asset servicing.

NTRS is a solid, well-capitalized asset servicer with genuine momentum, but at $186.27 the market has already recognized much of that. The one-time Visa gain muddies Q2, and forward EPS is below the trailing number, so the stock is not obviously cheap. I would be more interested closer to $170 or after Q3 confirms ex-item core earnings growth than at the current full price.

Applied a 15.5x forward P/E (a modest premium to NTRS's 5-year average of 14.7x, justified by clean CCAR, stronger ROE, and operating leverage) to consensus forward EPS of $11.47, yielding $177.79. This is below the current $186.27 because forward EPS excludes the one-time Visa gain and the consensus target is near $183.